Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Infographics: A Novel Approach to Improve Faculty-Preceptor Communication.

The Journal of nursing education·2024

Same author

Marital Satisfaction of Infertile Couples Using Natural Procreative Technology (NaProTECHNOLOGY).

Journal of Christian nursing : a quarterly publication of Nurses Christian Fellowship·2020

Same author

Competency-based education in transitioning nurse practitioner students from education into practice.

Journal of the American Association of Nurse Practitioners·2019

Same author

Knowledge of cardiovascular risk factors, self-nurturance, and heart-healthy behaviors in women.

The Journal of cardiovascular nursing·2011

Search research articles

Related Experiment Video

Updated: Jul 18, 2026

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Left ventricular assist devices as destination therapy.

Virginia Fidrocki Mason¹, Annette Jakubisin Konicki

¹Critical Care Nursing Educator, Caritas Saint Elizabeth's Medical Center, 736 Cambridge St, Our Lady Hall Room 515, Brighton, MA 02135, USA. Virginia_Mason@CCHCS.org

AACN Clinical Issues

|November 5, 2003

Summary

The shortage of donor hearts makes Left Ventricular Assist Devices (LVADs) crucial for heart failure patients. Advanced LVADs enable independent living, requiring nurses to adapt care for long-term mechanical circulatory support.

More Related Videos

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Experiment Videos

Last Updated: Jul 18, 2026

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Area of Science:

Cardiology
Medical Technology
Nursing Care

Background:

A significant gap exists between the need for heart transplants and the number performed annually in the US.
The shortage of donor hearts necessitates alternative solutions for patients with advanced heart failure.
Implantable Left Ventricular Assist Devices (LVADs) offer a promising alternative for improving patient survival.

Purpose of the Study:

To highlight the growing importance of LVADs as destination therapy.
To emphasize the evolving role of nursing in managing long-term LVAD patients.
To underscore the need for healthcare practitioners to understand LVAD technology for comprehensive patient care.

Main Methods:

Review of current statistics on heart transplantation and LVAD utilization.
Analysis of technological advancements in implantable circulatory assist devices.
Discussion of the implications for nursing practice in long-term LVAD care.

Main Results:

LVADs are increasingly approved as destination therapy, improving patient survival.
Smaller, battery-powered LVADs facilitate independent living for patients.
Long-term LVAD management requires proactive planning for extended care and emergencies.

Conclusions:

Nurses must adapt their practice to address the needs of a growing population of long-term LVAD recipients.
Anticipatory planning for extended care and emergency preparedness is essential for LVAD patients.
Healthcare providers need to be proficient in assessing and treating noncardiac issues in patients with mechanical circulatory support.